Topic
GLP-1 medications
5 stories related to this topic, newest first.
New York Postscience24 days ago
Study Links GLP-1 Drugs to Lower Cancer Progression in Four Types
A Cleveland Clinic analysis of 12,112 patients found lower rates of progression to stage 4 disease among those taking GLP-1 medications compared with DPP-4 inhibitors. The observational results will be presented at the 2026 ASCO Annual Meeting.
theconservativetreehouse.comworld40 days ago
Trump Administration Launches 18-Month Medicare Pilot Capping Copays at $50 for Certain GLP-1 Weight-Loss Drugs
President Donald Trump and the Centers for Medicare & Medicaid Services unveiled an 18-month pilot that will allow qualifying Medicare Part D beneficiaries to obtain certain GLP-1 medications such as Wegovy for $50 a month beginning July 1, 2026. The program marks a major policy…
manilatimes.networld44 days ago
Medicare to Test $50 Monthly Co-Pay for GLP-1 Weight Loss Drugs in New Pilot Program
The Centers for Medicare and Medicaid Services announced a two-year demonstration program that will allow certain enrollees to access FDA-approved GLP-1 medications for weight loss at a fixed $50 monthly co-pay with no deductible. The Medicare GLP-1 Bridge program runs from July…
AB
Nprscience46 days ago
Medicare to Test 18-Month GLP-1 Pilot for Weight Loss Drugs Starting July 2026
The Centers for Medicare & Medicaid Services will begin a short-term pilot on July 1, 2026, allowing eligible beneficiaries to obtain certain GLP-1 medications for weight loss at a flat $50 copayment. The 18-month program bridges to a potential longer-term initiative in 2028 afte…
news18.comfinance47 days ago
French Regulator Fines Novo Nordisk and Eli Lilly Over Weight Loss Drug Ads
France's medicines regulator imposed fines on Novo Nordisk and Eli Lilly for misleading advertisements related to their weight loss drugs. The penalties come amid launches of oral GLP-1 medications in the U.S., with Novo Nordisk's Wegovy pill gaining early traction. Company execu…